EVALUACIÓN PRELIMINAR DE LA TERAPIA CON PLASMA RICO EN PLAQUETAS SISTÉMICO (S-PRP) COMO ENFOQUE TERAPÉUTICO EN LA ENFERMEDAD RENAL CRÓNICA: UNA SERIE DE CASOS CLÍNICOS.
DOI:
https://doi.org/10.66104/50etnh37Palabras clave:
felinos, terapia sistémica, plasma, terapia regenerativa, factores de crecimiento, medicina integrativaResumen
La enfermedad renal crónica (ERC), una patología multifactorial caracterizada por inflamación tubulointersticial, atrofia tubular y fibrosis intersticial con función renal reducida, afecta a pacientes geriátricos, disminuyendo su calidad de vida. Ante la falta de un tratamiento definitivo, este estudio tiene como objetivo describir el uso de la terapia sistémica con plasma rico en plaquetas (PRP-P) como terapia adyuvante en tres gatos con ERC refractaria al tratamiento convencional. Los resultados mostraron una disminución en los niveles de creatinina y urea, así como una mejoría clínica. Se concluye que la terapia con PRP-P demostró una respuesta clínica y de laboratorio favorable en la estadificación de los tres pacientes tratados, lo que sugiere que podría ser una opción para pacientes con ERC.
Descargas
Referencias
ANDERSON, S.; RENNEKE, H. G.; BRENNER, B. M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in rats. Journal of Clinical Investigation, v. 77, n. 6, 1986. DOI: https://doi.org/10.1172/JCI112528
BROWN, Scott A. et al. chronic kidney disease in aged cats: clinical features and management. Veterinary Clinics of North America: Small Animal Practice, v. 46, n. 6, p. 1015–1032, 2016. DOI: https://doi.org/10.1016/j.cvsm.2016.06.002
HUNTINGFORD, J.; LOONEY, A.; JOHNSON, J.; MILLER, L. The Use of Platelet Rich Plasma in the Treatment of Degenerative Joint Disease in Cats: An Exploratory Case Series. Companion Publications / Clinical Trial, set. 2024. DOI: https://doi.org/10.3389/fvets.2024.1394055
IRIS – INTERNATIONAL RENAL INTEREST SOCIETY. Guidelines for Chronic Kidney Disease in Cats. 2024. Disponível em: https://www.iris-kidney.com. Acesso em 10 de março de 2025.
LANA, José F. S. D.; MORAES, Tomas M. S.; JORGE, Daniel M. F; FONSECA, Lucas F.; RODRIGUES, Bruno L. Medicina regenerativa. Indaiatuba: Brasil Sustentável Editora, 2025.
OLSZEWER, Efrain; ARROYO, Emil; NAKAMURA, Flávia. PRP: plasma rico em plaquetas. São Paulo: FAPES Books, 2015.
POLZIN, David J. Chronic kidney disease in small animals. Veterinary Clinics of North America: Small Animal Practice, v. 41, n. 1, p. 15–30, 2011. DOI: https://doi.org/10.1016/j.cvsm.2010.09.004
SPARKES, Andrew H. et al. ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease. Journal of Feline Medicine and Surgery, v. 18, n. 3, p. 219–239, 2016. DOI: https://doi.org/10.1177/1098612X16631234
VENDRUSCOLO, Carolina P. et al. Uso do plasma rico em plaquetas na medicina veterinária. Pesquisa Veterinária Brasileira, v. 38, n. 5, p. 865–875, 2018.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2026 Flavia Gill Ricco, Domingos Savio de Aquino Junior, Maira Mendonça Braz de Andrade
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
